Morgan Stanley’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Sell
18,376
-340,078
-95% -$279K ﹤0.01% 6887
2025
Q4
$326K Buy
358,454
+175,905
+96% +$169K ﹤0.01% 5724
2025
Q3
$163K Sell
182,549
-262,946
-59% -$383K ﹤0.01% 5967
2025
Q2
$962K Buy
445,495
+135,151
+44% +$490K ﹤0.01% 5116
2025
Q1
$1.49M Buy
310,344
+95,113
+44% +$542K ﹤0.01% 4788
2024
Q4
$1.39M Buy
215,231
+199,321
+1,253% +$970K ﹤0.01% 4926
2024
Q3
$63.8K Buy
15,910
+4,887
+44% +$20.2K ﹤0.01% 6149
2024
Q2
$35.4K Hold
11,023
﹤0.01% 6273
2024
Q1
$36K Sell
11,023
-14,403
-57% -$52.2K ﹤0.01% 6328
2023
Q4
$127K Buy
25,426
+15,403
+154% +$41K ﹤0.01% 6085
2023
Q3
$11.1K Buy
10,023
+10,000
+43,478% +$8.49K ﹤0.01% 6696
2023
Q2
$12 Hold
23
﹤0.01% 7597
2023
Q1
$17 Sell
23
-13,491
-100% -$7.89K ﹤0.01% 7648
2022
Q4
$6.91K Buy
13,514
+13,490
+56,208% +$13.4K ﹤0.01% 7061
2022
Q3
$0 Sell
24
-5
-17% -$9 ﹤0.01% 7815
2022
Q2
$0 Sell
29
-939
-97% -$2.46K ﹤0.01% 7908
2022
Q1
$4K Sell
968
-12,596
-93% -$84.3K ﹤0.01% 7640
2021
Q4
$93K Sell
13,564
-11,212
-45% -$107K ﹤0.01% 6491
2021
Q3
$295K Sell
24,776
-41,497
-63% -$413K ﹤0.01% 5795
2021
Q2
$715K Sell
66,273
-209,793
-76% -$2.19M ﹤0.01% 5286
2021
Q1
$3.53M Buy
276,066
+276,040
+1,061,692% +$3.34M ﹤0.01% 3769
2020
Q4
$0 Hold
26
﹤0.01% 7079
2020
Q3
$0 Hold
26
﹤0.01% 6797
2020
Q2
$0 Hold
26
﹤0.01% 6678
2020
Q1
$0 Sell
26
-1
-4% -$7 ﹤0.01% 6650
2019
Q4
$0 Sell
27
-39
-59% -$622 ﹤0.01% 6715
2019
Q3
$1K Buy
66
+6
+10% +$137 ﹤0.01% 6558
2019
Q2
$1K Sell
60
-5
-8% -$154 ﹤0.01% 6556
2019
Q1
$2K Buy
65
+16
+33% +$682 ﹤0.01% 6456
2018
Q4
$2K Hold
49
﹤0.01% 6421
2018
Q3
$3K Sell
49
-287
-85% -$18.9K ﹤0.01% 6512
2018
Q2
$30K Buy
336
+246
+273% +$24.7K ﹤0.01% 6045
2018
Q1
$8K Buy
90
+28
+45% +$3.39K ﹤0.01% 6309
2017
Q4
$7K Buy
62
+7
+13% +$837 ﹤0.01% 6284
2017
Q3
$10K Buy
55
+27
+96% +$6.48K ﹤0.01% 6172
2017
Q2
$9K Buy
+28
New +$10.3K ﹤0.01% 6264

Other funds holding MYO

Morgan Stanley's MYO Position: Q1 2026 in Review

Morgan Stanley reduced its Myomo (MYO) stake by 95% in Q1 2026, selling an estimated $279K and leaving 18,376 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6887.

Morgan Stanley first reported a position in MYO in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.53M in Q1 2021. 80 funds tracked by Wall St. Rank hold MYO as of Q1 2026.

  • Morgan Stanley held 18,376 shares of Myomo worth $12.4K as of Q1 2026.
  • Morgan Stanley sold 340,078 Myomo shares in Q1 2026, an estimated $279K.
  • Myomo made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6887 holding.
  • Morgan Stanley first reported a position in Myomo in Q2 2017 and has held it in 36 quarters since.
  • Morgan Stanley's Myomo position peaked at $3.53M in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.